AU2015904770A0 - Compounds and methods for treating metabolic disorders - Google Patents

Compounds and methods for treating metabolic disorders

Info

Publication number
AU2015904770A0
AU2015904770A0 AU2015904770A AU2015904770A AU2015904770A0 AU 2015904770 A0 AU2015904770 A0 AU 2015904770A0 AU 2015904770 A AU2015904770 A AU 2015904770A AU 2015904770 A AU2015904770 A AU 2015904770A AU 2015904770 A0 AU2015904770 A0 AU 2015904770A0
Authority
AU
Australia
Prior art keywords
compounds
methods
metabolic disorders
treating metabolic
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015904770A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Publication of AU2015904770A0 publication Critical patent/AU2015904770A0/en
Priority to US15/777,510 priority Critical patent/US20180369325A1/en
Priority to PCT/AU2016/051112 priority patent/WO2017083925A1/en
Abandoned legal-status Critical Current

Links

AU2015904770A 2015-11-19 2015-11-19 Compounds and methods for treating metabolic disorders Abandoned AU2015904770A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US15/777,510 US20180369325A1 (en) 2015-11-19 2016-11-18 Compounds and methods for treating metabolic disorders
PCT/AU2016/051112 WO2017083925A1 (en) 2015-11-19 2016-11-18 Compounds and methods for treating metabolic disorders

Publications (1)

Publication Number Publication Date
AU2015904770A0 true AU2015904770A0 (en) 2015-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3328376A4 (en) Methods and compositions for treating metabolic reprogramming disorders
EP3359168A4 (en) Therapeutic compounds and methods
EP3265053A4 (en) Methods for treating skin
EP3212226A4 (en) Compositions and methods of use for treating metabolic disorders
EP3229812A4 (en) Synthetic composition for treating metabolic disorders
EP3500289A4 (en) Methods for treating tracheobronchomalacia
EP3247359A4 (en) Composition and method for treating seizure disorders
EP3380121A4 (en) Methods for treating eye disorders
EP3174894A4 (en) Compositions and methods of use for treating metabolic disorders
EP3331550A4 (en) Methods for treating myeloproliferative disorders
IL279308A (en) Methods for treating hepcidin-mediated disorders
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3283655A4 (en) Methods for treating myeloproliferative disorders
EP3134120A4 (en) Compositions and methods for treating cytokine-related disorders
PL3524255T3 (en) Composition for the treatment of acne
EP3189036A4 (en) Compositions and methods for treating proliferation disorders
EP3125908A4 (en) Compositions and methods for treating kidney disorders
EP3166610A4 (en) Methods for treating neurologic disorders
EP3008167A4 (en) Compositions and methods for treating metabolic disorders
EP3142699A4 (en) Compositions and methods for treating metabolic disorders
EP3122872A4 (en) Compositions and methods for treating type 1 and type 2 diabetes and related disorders
EP3240577A4 (en) Methods and compositions for treating brain diseases
EP3331499A4 (en) Composition and method for treatment of metabolic disorders
EP3194027A4 (en) Methods and compositions for treating psychotic disorders
EP3322406A4 (en) Transpapillary methods and compositions for treating breast disorders